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Neuroscience research in Africa remains sparse. Devising new policies to boost Africa’s
neuroscience landscape is imperative, but these must be based on accurate data on research
outputs which is largely lacking. Such data must reflect the heterogeneity of research
environments across the continent’s 54 countries. Here, we analyse neuroscience publica-
tions affiliated with African institutions between 1996 and 2017. Of 12,326 PubMed indexed
publications, 5,219 show clear evidence that the work was performed in Africa and led by
African-based researchers - on average ~5 per country and year. From here, we extract
information on journals and citations, funding, international coauthorships and techniques
used. For reference, we also extract the same metrics from 220 randomly selected pub-
lications each from the UK, USA, Australia, Japan and Brazil. Our dataset provides insights
into the current state of African neuroscience research in a global context.
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Africa accounts for 15% of the global population but 25% ofthe global disease burden1. Moreover, the continent hasthe world’s largest human genetic diversity, with impor-
tant implications for understanding human diseases2, including
neurological disorders3,4. However, even though early progress in
neuroscience began in Egypt5, Africa’s research capacity in this
area has not kept pace with the developments in the field6.
The reasons for this are diverse, and include low funding1,
inadequate research infrastructure7, the relatively small number
of active scientists8, and their high level of administrative and
teaching load[9,10. These barriers limit research and innovations
from Africa11, and contribute to the ‘brain drain’ from the region
that extends long beyond neuroscience itself12.
Over recent decades, an increasing number of local and inter-
national initiatives were set up to address some of these challenges,
including in neuroscience13. This seems to have led to some pro-
gress, as for example, seen in a steady rise in the number of pub-
lications affiliated to some of the continent’s countries with
traditionally high numbers of neuroscience publications such as
South Africa, Egypt or Nigeria14. Of the overall publications from
Sub-Saharan Africa, almost 70% have non-African-based authors6.
While on the one hand this may be indicative of important colla-
borative links between Africa and the rest of the world, it leaves it
unclear which studies were truly African-led, and carried out in
African labs—and which were rather led by researchers based
elsewhere6,15. Indeed, a previous estimate suggested that as much as
80% of published health research that included African authors in
Burkina Faso was not African led16. Here, we use the term (African
led) to mean publications with clear evidence (e.g based on lead and
senior author affiliations, and/or on manually asserted study loca-
tion, where available) that the bulk of the intellectual input and
experimental work was carried out by researchers who are primarily
based at African institutions (‘Methods’).
Scientific publication database mining approaches using a
combination of search terms such as ‘Neuroscience’ and ‘Africa’
have been used to estimate neuroscience research outputs from
Africa by way of quantifying publication trends14,17. However,
this approach does not delineate African-led studies from those
led by researchers elsewhere. For example, PubMed data mining
identifies 1247 Nigerian-led neuroscience papers between 1996
and 2017. However, manual curation revealed that of those, 54%
were led by non-Nigerian laboratories15. Many of the remaining
46% Nigerian-led studies were published in Africa-based journals,
some of which attract few citations from institutions outside
of Africa15. Despite the importance of genetically modified
model systems in driving neuroscience research breakthroughs,
Nigerian-led studies were characterised by a general absence of
genetically modified animal model systems and only occasional
use of more resource-intensive techniques such as advanced
fluorescence microscopy or neuroimaging15. However, while
these country-specific analyses are valuable, in view of the con-
tinent’s geographical, political and cultural diversity, further
research is needed beyond a single country.
To survey African-led neuroscience publications as a whole, we
here developed a measure that involves manual curation of
PubMed-retrieved articles to ascertain whether they were led by
researchers who were primarily affiliated and based at African
institutions. Accordingly, we manually went through each of
12,326 PubMed-listed neuroscience publications affiliated with
African institutions between 1996 and 2017. We identified those
that presented clear evidence that the research was indeed carried
out in Africa (see above, and ‘Methods’). This eliminated ~58% of
publications to leave 5219, on average, five per country and year.
From here, we extracted key metrics, including author affiliations,
the field of neuroscience, journals and citations, as well as
information on funding, models and techniques. For comparison,
we also extracted the same metrics from 220 randomly selected
publications, each from the UK, USA, Australia, Japan and Brazil,
of which 79% passed our inclusion criteria (Fig. S1).
We here present a summary of our main findings. Specifically,
we asked: How many publications came out of each African
country, and how were different sub-disciplines represented
(Fig. 1)?, in which journals are they published and how many
citations did they attract (Fig. 2)?, what were the major trends of
international co-authorships (Fig. 3)?, how was the work funded
(Fig. 4)?, and what experimental techniques were used (Fig. 5)?
Results
African neuroscience by numbers of publications. Africa’s
neuroscience publications since 1996 (n= 5219 publications, see
introduction) have been dominated by a small number of coun-
tries: Egypt (n= 1478, 28%), South Africa (n= 1181, 23%),
Nigeria (n= 566, 11%), Morocco (n= 409, 8%) and Tunisia (n=
388, 7%) (Fig. 1a). Together, these five countries account for more
than three in every four neuroscience papers published from the
continent. At 2–3% each, further contributions came from the
East African nations of Kenya (n= 131), Ethiopia (n= 119) and
Tanzania (n= 103), followed by 1–2% each from Cameroon (n=
81), Malawi (n= 71), Algeria and Senegal (n= 70 each), Uganda
(n= 69) and Ghana (n= 60). Beyond these, numbers per country
are lower, with more than half of African countries contributing
fewer than 10 papers. Nevertheless, over the past two decades, the
number of neuroscience publications published each year has
exponentially increased across all of Africa’s major geopolitical
regions (Fig. 1b). Accordingly, the continent’s number of neu-
roscience publications is on an all-time high with a clear upwards
trajectory (see also Fig. S2A).
Here, dominant research schemes18 include neurodegeneration
and injury (n= 2066, 34%; compared to 22% outside of Africa
(OA)), followed by techniques (n= 905, 15%; OA: 16%),
excitability, synapses and glia (n= 550, 9%, OA: 15%), development
(n= 532, 9%; OA: 16%), and physiology and behaviour (n= 511,
8%; OA: 13%) (Fig. 1c). In comparison, research on motivation and
emotion (n= 217, 4%; OA: 3%), motor systems (n= 191, 3%; OA:
9%), cognition (n= 155, 3%; OA: 4%) and sensory systems (n= 92,
2%; OA: 2%) is less prevalent. By and large, and despite a small
degree of inevitable variation, this general distribution across major
neuroscience research schemes has been surprisingly constant, both
across countries (Fig. 1a), and over time (Fig. S2B).
The visibility of African neuroscience publications. There is no
single, universally useful metric for measuring research visibility
and influence. Metrics like journal impact factor (IF, i.e. the yearly
average number of citations of articles published in the last two
years in a given journal) and citation counts have many
shortcomings and vary across research fields. Nonetheless, in
the absence of perhaps less problematic numerical approaches, we
compared these two metrics in relation to African neuroscience
publications across countries. For global context, we computed
the same metrics for 220 randomly selected papers each from the
USA, UK, Japan, Australia and Brazil. This revealed a great
diversity of African research visibility, with many papers ranking
on par with many non-African papers (Fig. 2a). However, dif-
ferent regions varied markedly in the distribution of these
metrics. For example, with a mean of ~13 citations per paper,
West-African publications tended to be cited least frequently. In
contrast, Southern Africa’s publications were on average cited 31
times, on par with those coming from Brazil. Nevertheless,
though dominated by the Global North (here: UK, USA, Japan,
Australia, mean of ~77 citations per paper), also researchers from
most African regions published at least a small fraction of papers
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in the top bracket (citations ≥ 95). These trends were largely
mirrored also in the publishing journal’s IF (Fig. 2b, c). However,
unlike for citations, very few publications from African labs
ranked in the top bracket (here arbitrarily defined as IF ≥ 9.5),
which supports frequently discussed shortcomings of this metric
for the assessment of individual manuscripts19,20. Together, even
though for now much of global neuroscience research remains
dominated by the Global North, the number of neuroscience
publications from African labs is undeniably growing.
Co-authorship with international authors. One key aspect of
integration into the global research community comes through
international scientific collaborations. Here, the lack of funding
and barriers related to visa processes have long made it difficult
for many African researchers to engage with colleagues
abroad21. However, where these difficulties have been overcome,
publication and citation metrics do stand to gain. For example,
African-led neuroscience publications with international-based
co-authors—both within Africa and beyond—tended to be cited
more frequently, and were published in higher IF journals
(Fig. 3A). Perhaps unsurprisingly, the capacity for international
co-authorship is therefore associated with research visibility22.
We therefore next investigated how Africa’s co-authorship
networks are geographically organised.
Fig. 1 African neuroscience publications 1996–2017. a Overview of Africa’s neuroscience publications in the timeframe indicated, organised in nine broad
topics as indicated by the different colours. Bubble sizes denote the total number of papers per country and topic, as indicated. b Total publications per
year, with contributions from different African regions highlighted. Regions were delineated following the United Nations definition into North Africa, West
Africa, East Africa, Central Africa and Southern Africa. See also background shading in (a). c Distribution of research topics in Africa (coloured bars, for
legend see (a)) and outside of Africa (grey bars). Source data are provided as a Source Data file.
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This revealed that besides collaborating domestically, African
Neuroscientists rarely published with co-authors across long
distances within Africa, instead, co-authorship with researchers
outside the continent of Africa was more common (Fig. 3B–D).
In particular, many internationally co-authored papers had links
with either Europe or North America. Similarly, any intra-African
co-authorships were mostly with contributions from other
African regions with overall higher publication outputs. For
example, West, East and Central African-led studies occasionally
included co-authors from Southern Africa, while vice versa
Southern African-led papers almost never had East- West- or
Central African co-authors (Fig. 3B). All the while, papers from
North Africa mostly included co-authors from Europe, North
America and the Middle East. The latter examples follow a
geographic and cultural pattern23,24, for example, in terms of
shared dominant religions and languages. Generally, fractions of
international co-authorship of publications increased over the
study period, with approximately preserved geographical patterns
(Fig. S2C).
Overall, the striking preponderance of co-authorship beyond
Africa’s borders over pan-African international links is reminiscent
of the continent’s logistical networks—here exemplified by available
international flights (Fig. 3E, F). It seems likely that both networks
are linked to common underlying factors such as historical,
linguistic and cultural ties as well as economic considerations24.
Nevertheless, this currently poor international connectedness within
the continent ought to be considered in future efforts aiming to
build a more united African research landscape.
Funding African neuroscience. We next asked how Africa’s
neuroscience research is funded. To this end, we assessed funding
declarations in Africa’s 265 top papers (‘Methods’). Of these,
many (n= 93, 35%) declared no funding at all (Fig. 4a). This lack
of declarations was pervasive throughout the continent, but
particularly prominent in Northern Africa (n= 46 of 73, 63%).
Many of these studies may have been self-funded, and/or pub-
lished in outlets that do not require a funding declaration.
Of papers that did declare the funding (n= 172), we next
assessed whether the sources were domestic and/or international
(Fig. 4b). This revealed that most of these African neuroscience
publications were supported by international rather than
domestic agencies. For example, only 3 out of 37 (8%) of East
African top papers declared domestic funding, while 36 (97%)
declared international funding. The only African region where
the number of domestic funding mentions exceeded international
funding mentions was Southern Africa: (n= 49 (73%) domestic
and n= 32 (48%) international; of n= 67 total). In comparison,
between 92% (UK) and 100% (Brazil) of papers included in our
analysis declared domestic funding, with between 9% (Japan) and
57% (Australia) of papers declaring additional international
support. It seems clear that the availability of local, rather than (or
in addition to) international funding is critical to building a viable
research culture, and Southern Africa appears to be the only
region that is beginning to reflect this need. Indeed, South Africa,
by far Southern Africa’s largest research contributor, is the only
country in Africa that invests nearly 1%, of its GDP in research
and development, as recommended by the African Union in
20071.
Nevertheless, 46% (n= 123) of Africa’s 265 top neuroscience
papers declare international funding, hinting that these factors may
be linked. The vast majority of this support came from the USA,
who supported n= 44 (36%) of these 123 papers, followed first by
the UK (n= 31, 25%), and then France (n= 11, 9%), Switzerland
(n= 9, 7%) and Germany (n= 7, 6%) (Fig. 4c, d). Accordingly,
unlike manuscripts with international co-authorship (Fig. 3D),
international funding support from the Middle East, Asia, Australia
and South America for African neuroscience was limited. By
agency, the USA’s NIH was acknowledged most frequently (n= 42,
34%), followed by the UK’s Wellcome Trust (n= 24, 20%) and
Medical Research Council (n= 10, 8%). Next was the World Health
Organisation (n= 6, 5%), and beyond this, no agency received
more than 2% of international funding mentions.
Model systems, techniques and medicinal plants. Advances in
our understanding of nervous systems are notably driven by equally
rapid advances in (bio)technology. Accordingly, access to state-of-
the-art research tools—both technological and biological—remain
central to scientific success. Accordingly, understanding the avail-
ability and use of such tools across Africa is likely to be pivotal to
any strategy to support future research. To this end, we categorised
methods employed in each of the surveyed >6000 papers as either
‘type 1’ and ‘type 2’, where type 1 techniques can generally be
supported already with minimal infrastructural investment (e.g.
classical histology, chromatography and/or behaviour), type 2 was
Fig. 2 Citations and journal impact factors. a, b Area-normalised histograms of citations (a) and the publishing journal’s impact factor (IF, b) of all papers
from different African and non-African regions, as indicated. In each case, all citations above ≥95, and IF above ≥9.5 were allocated to a single bin (top).
c Citations plotted against IF for every paper in the database (small grey dots), and for means by country (large dots), as indicated. Linear correlation
coefficients as indicated. Source data are provided as a Source Data file.
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aimed to summarise the use of more resource-intensive techniques
that traditionally come in hand with substantial investment in
research infrastructure (e.g. fluorescence microscopy, molecular
biology, cell culture work, neuroimaging; for a full list of criteria, see
‘Methods’). Despite this set of arguably conservative criteria, and
with the notable exception of The Gambia (n= 5/14; 36%, all
linked to an MRC-funded research unit), no African country’s
neuroscience publications comprised more than a quarter of
type 2 entries (Fig. 5a1,2). African countries with highest use of
type 2 techniques were Egypt (n= 363/1478; 25%), South Africa
Fig. 3 Co-authorships. A1 Citations plotted against the journal impact factor (IF) for each African country, divided into publications without (grey, ‘solo’) and
with international co-authors (pink, ‘coauthored.’). The latter included both within-Africa international co-authors as well as co-authorships beyond Africa’s
borders. Square-markers and errors denote each population’s mean and s.d. Both citations and IFs were significantly higher for internationally co-authored
papers (Wilcoxon Rank Sum, 1-tailed, ***p < 0.001, full p values: 7.7 × 10−15 and 1.1 × 10−12 for citations and IF, respectively; n= 45 countries in both cases).
A2 The same citation data as (A1) plotted pairwise for with (y-axis) and without international co-authors (x-axis), highlighting the substantial positive influence
of international co-authors. Dotted line indicates parity. B Co-authorship matrix between African regions and the rest of the world, with darker colours indicating
a higher preponderance of international co-authorships. C, D Intra-African (C) and Beyond-African (D) co-author links organised by African country and major
geopolitical regions beyond Africa, as indicated. The thickness of lines illustrates the total number of internationally co-authored papers, while colourings in (D)
illustrate the co-authorships with partner beyond Africa. E, F as (C, D), respectively, but for the existence of international flight routes based on data from
OpenFlights.org. Each route is illustrated with a single line of consistent opacity and thickness. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23784-8 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3429 | https://doi.org/10.1038/s41467-021-23784-8 | www.nature.com/naturecommunications 5
(n= 272/1181; 23%), Morocco (n= 68/409; 17%), Tunisia (38/388;
10%), Nigeria (45/566; 8%), Ethiopia (9/119; 8%) and Algeria (2/35;
6%). All other African countries ranked below 5%, including many
at 0% (countries with fewer than 10 papers were excluded from this
analysis). In contrast, Japan, UK and USA all published 75% of
papers based on type 2 techniques, followed by Australia (54%) and
Brazil (33%).
Next, there was a near-complete absence of small, low cost and
genetically tractable model systems such as fruit flies, zebrafish or
Caenorhabditis elegans25 in African neuroscience publications
(Fig. 5b1,2). Unlike USA (33%), UK and Japan (23%), Australia
(12%) or Brazil (3%), no African country used any genetically
modified model systems (including cell culture or mammals) in
more than 1% of neuroscience publications. Most countries used
none at all. Clearly, the promotion of the use of such model
systems should be considered as part of strategies aimed to
modernise Africa’s research landscape.
Finally, we assessed the use of endemic medicinal plants in
African neuroscience publications, many of which have been used
for centuries for the treatment of diseases. Research in natural
medicinal products puts Africa in an excellent position in the area
of drug discovery26. This revealed that research in this field is highly
diverse across the continent (Fig. 5c1,2). In particular, several West-
African countries with tropical and subtropical climates have
Fig. 4 Funding. a Percentage of papers with IF≥ 5 that included any form of funding acknowledgements. b From (a), where declared, the source of funding,
classified as domestic (black) and international (brown). International funding includes those received from any other country, including other African
countries. Percentages are computed from each paper declaring either domestic or international support, or both. c Percentages of funder mentions of all
African papers with IF≥ 5 where international funding was declared (corresponding to the sum of brown columns in (b)). Where present, multiple funder
mentions per single paper were individually included. d International funding links from (b, c) displayed by geography. Each funding mention is illustrated
with a single line of consistent opacity and thickness. Source data are provided as a Source Data file.
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invested heavily into this branch of neuroscience, most notably
Cameroon (30%) as well as Nigeria and Ghana (18% each). In
contrast, many other countries, including both of Africa’s most
prolific contributors to neuroscience publications (Egypt 5% and
South Africa 1%), are more focused on other topics.
Discussion
Our dataset highlights that Africa’s neuroscience publication
numbers and their citations are on an all-time high, with a clear
and ongoing upwards trajectory. Similarly, while the number of
neuroscientists in the continent remains tiny compared to the
total population (e.g. Refs. 27–29), the neuroscience scientific
workforce is on the rise. This is, for example, mirrored in the
increasing number of neuroscientists attending the Society of
Neuroscientists of Africa (SONA) bi-annual meetings30, or a
continuous rise in the number of applications for African-based
neuroscience training programmes. However, to continue sup-
porting this growth, major and ongoing investment into African
science must be ensured.
Most declared neuroscience funding came from external
sources, most notably from the USA and the UK. However, local
Fig. 5 Research techniques. a1–c1, Percentages of papers that used ‘type 2’ techniques (‘Methods’) (a1), transgenic models (b1) or medicinal plants (c1),
organised by geography. Countries with fewer than 10 papers in the dataset were excluded (grey). a2–c2 As (a1–c1), plotted as percentage bars per country,
with the same metrics extracted from representative non-African publications (blue). African countries are sorted by the total number of papers published
(a2, top), excluding countries with fewer than 10 papers in the database. Source data are provided as a Source Data file.
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funding is instead needed for establishing a sustainable African
neuroscience research environment. At the moment, none of
Africa’s 54 countries invests as much as 1% of their GDP into
R&D, as recommended by the African Union1. South Africa is
one of the few countries nearly meeting this target, which likely
part-explains its leading role in African neuroscience. Compared
to other African countries, the high proportion of domestic
funding in South Africa might be part-explained by its national
policy changes in the research and development budget. In 2003,
the South African government issued a new funding scheme that
directs funding to tertiary institutions based on their research
output. Since 2012, South Africa’s gross expenditure on research
and development (GERD) has consistently increased according to
the national R&D survey31.
For African research to continue to grow, more government
funding is needed to provide reliable support to their domestic
research sector. Such efforts might also be well-supported by the
local philanthropic sector. Africa has a large number of indivi-
duals and charitable organisations with access to substantial
funds32. Governments, scientists and the general population must
engage with these to contribute to local science funding, much
like major non-African philanthropic organisations such as the
Gates Foundation or Wellcome Trust that currently fund research
on the African continent. African Neuroscientists may also seek
to facilitate further international networking and collaboration
opportunities, particularly within Africa, in view of attracting
multinational funding33. In addition, increased engagement with
science advocacy campaigns to raise the profile of African
research and its relevance to both global and local problems may
be expected to further facilitate their cause. This is particularly
relevant given the continents genetic diversity which can help in
understanding global health problems2. Advocacy campaigns
could focus particularly recognisable disease aspects such as
central nervous system (CNS) infections (e.g. cerebral meningitis)
or konzo. Increased awareness of African-led research in fields
such as these, and their benefits to society, may translate to
increased support and provision for funding.
Indeed, already now, many African neuroscience articles under
the Neurodenegerative Disorders and Injury theme were studies
on meningitis, konzo, stroke, neurological manifestations of HIV,
and epilepsy. In general, these areas were the most intensely
studied neuroscience research themes in Africa, which may also
reflect an increased awareness about the prevalence of these
conditions amongst scientists, policymakers and the general
public. In support, previous work reported a dementia incidence
rate in Africa between <1% and 10% in population-based studies,
and up to 47.1% in hospital-based studies34. For traumatic brain
injury (TBI), the 2016 Global Burden of Disease study35 esti-
mated nearly six million cases across all of Africa, the highest of
any continent. By 2050, the prevalence of TBIs in Africa is pre-
dicted to further rise, to between 6 and 14M cases annually36.
Similarly, compared to most non-African countries, Africa’s
incidence rate of epilepsy is expected to double37 alongside a
projected increase in the prevalence of stroke38. Beyond the cri-
tical need for global recognition and action on these issues, they
also provide a powerful platform for lobbying more generally for
additional support of African neuroscience research.
Although there is clear evidence of increasing numbers of
neuroscience publications from African laboratories, there is still
much room for growth. Based on citation and IF metrics, there
remains substantial heterogeneity in the visibility of the neu-
roscience publications across the continent. Under the caveat that
using such metrics as a shorthand for ‘research quality’ is not
appropriate19,20, West Africa seems to lag behind among all the
regions. For example, Nigeria, the region’s country with the
greatest number of publications, published only one neuroscience
paper in an IF ≥ 9.5 journal in the 21-year period15. The lack of
visibility, especially in citations, may be part-explained by choices
over where work is submitted for publication. Many Nigerian
neuroscience papers are published in African journals, many of
which are rarely read beyond the continent’s borders15. More-
over, many African journals are not PubMed indexed (and
therefore excluded from our study)39. Given the clear benefit of
publishing in indexed journals for driving research and colla-
boration, this flags the need for African academics to increasingly
target indexed journals. This will be facilitated by increasing the
widespread availability of both author and of access fee-waivers
from international outlets40.
Next, our analysis highlights a profound lack of the availability
and/or use of state-of-the-art equipment and modern experi-
mental approaches. With few notable exceptions, tools like
fluorescence microscopy, molecular biology or cell culture were
used in less than 10% of most African countries’ neuroscience
publications (see also Ref. 15). Next, while some public institu-
tions have some type 2 equipment located in individual depart-
ments, access is often restricted to a small number of researchers
which can limit their widespread use15,40. Although funding
schemes and training programmes have enabled many African
scientists to acquire diverse neuroscience skills in foreign labs, the
absence of the same research infrastructure back at their home
institutions continues to restrict the extent to which such skills
can be put into use. Clearly, beyond financial investment, African
researchers must be afforded widespread access to diverse
research infrastructure9. In addition to the provision of training
opportunities abroad, local and international neuroscience
funding initiatives should support African scientists to establish
their laboratories. Similarly, African labs have much to gain from
investing in infrastructure and expertise in designing and pro-
ducing research-grade open hardware equipment9,41–43.
Finally, the near-complete absence in the use of transgenic
models in African neuroscience publications is worrying, and
may contribute to the generally low citation number of African
neuroscience publications. Instead, many African neuroscientists
continue to rely on wild-type rodent models, most notably rats,
followed by mice15. The cheap and genetically amenable nature of
model systems like zebrafish, fruit flies or C. elegans, makes these
models ideal. One-third of the Nobel Prizes in Physiology and
Medicine awarded between 1996 and 2017 relied heavily on non‐
mammalian yet genetically accessible model systems44. The many
challenges faced by African neuroscience, most notably lack of
funding, make ultra-low-cost models like fruit flies and C. elegans
particularly interesting for research on the continent45. This
particularly calls for increased investment to facilitate the use of
these and other similar affordable and genetically amenable
model species in African neuroscience. For this, scientists and
funding agencies will also need to work closely with national
governments and biosafety authorities to put regulation for the
import and use of genetically modifiable animals in place, which
to date is missing in many African countries.
Taken together, while the number of African neuroscience
publications remains comparatively small, it is clearly on the rise.
To sustain this rise and increase the continent’s neuroscience
visibility, there is a clear need for increased investment in modern
research equipment, training in the use of this equipment and the
adoption of genetically tractable models. While some of this
investment will likely continue to come from beyond Africa’s
borders, it will be critical to bolster African countries’ domestic
research support streams, from governments and private funders
alike. Next, while international collaborations are valuable, Afri-
can neuroscience must in parallel be strengthened through intra-
African collaborations and the promotion of sharing of restricted
resources.
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In view of the highly interdisciplinary nature of neuroscience,
many aspects of our findings may potentially generalise to other
scientific disciplines.
Methods
Data extraction. Neuroscience-related research articles from Africa, USA, UK,
Australia, Japan or Brazil from January 1996 to December 2017 were retrieved
from PubMed. Search terms used were ‘neuroscience’ OR ‘nervous system’ OR
‘brain’ OR ‘neuron’ OR ‘spinal cord’, in combination with the name of each of the
individual African and non-African countries were used. The searches also
included author affiliation fields, as well as the full text—from here, a small number
of false-positives (e.g. where a paper mentioned a specific African country in the
full text with the research having been carried out elsewhere) were excluded by
hand. Primary research, case reports or clinical trials were included, while review
articles were excluded. Next, duplicates (~10%) and irrelevant articles were
manually removed. This yielded a total of 12,326 candidate papers from Africa. For
comparison, 220 papers each from the above-listed non-African countries were
also analysed, after randomly selecting 10 publications per year and country using
the same search terms (Fig. S1). Of the total of 1100, n= 229 (21%) were elimi-
nated based on the same exclusion criteria applied to our African dataset to leave a
total of n= 871 non-African papers (Australia: 164; Brazil: 173; Japan: 197; UK:
171; USA: 166).
Data curation. Most data curation was done by hand, as detailed below. All raters
were trained neuroscientists, with experience ranging from MSc level to faculty.
Rating practice was aligned first by the lead author training all raters individually.
Subsequently, each paper was independently rated twice, by two different members
of the team, followed by manual checking and adjusting by the first author for any
inconsistencies between each paper’s two ratings. Curators per country were
chosen such that all of a given country’s publications were curated by the same two
curators (and, if needed, the lead author, as noted above). To identify research
conducted within each country, the full texts of all the articles were retrieved and
screened manually. For exclusion, papers from outside of Africa were identified
based on the listed affiliations of lead/corresponding/senior author(s) as well as
study location. The latter was extracted from information in the materials and
methods or acknowledgements, where possible. For example, articles with external
co-authorships in which only a small fraction of the work was conducted within
Africa, such as sample collection, were excluded. Moreover, even if the authors did
not have an affiliation with an African institution, their work was included as long
as it was conducted within Africa (as judged, e.g. from methods and/or acknowl-
edgements sections). This process eliminated n= 7107 papers, leaving n= 5219
African papers for further analysis (Fig. S1). For simplicity, we did not attempt to
quantify our dataset by individual contributing author. This is because of the
difficulty in reliably linking individual authors across publications that may use a
variety of name-formatting in the author list, and because unique author identifiers
such as ORCIDs were not reliably listed in all surveyed papers.
The latter were further screened by hand to retrieve the total number of google
scholar citations, the publishing journal and its Clarivate Analytics impact factor,
as well as information on model species whether or not they used medicinal plants.
Impact factor for journals not indexed by Clarivate Analytics was estimated from
Scimago. In addition, author affiliations were screened for co-authorships between
research institutes, both nationally and internationally. In addition, we summarised
each paper’s research techniques as either ‘type 1’ or ‘type 2’: Type 1 techniques
included histology, biochemical assays, such as enzyme‐linked immunosorbent
assay (ELISA), plant extract preparation, high‐performance liquid chromatography
(HPLC), behaviour and blood analysis. Type 2 included electron microscopy,
western blotting, immunohistochemistry, cell culture techniques, cloning, flow
cytometry, fluorescence microscopy, whole-brain imaging, advanced neuroimaging
(e.g. fMRI), sequencing and identifying genes of interest, molecular cloning and
recombinant DNA technology, gene delivery strategies, making and using
transgenic organisms, manipulating endogenous genes, as well as any additional
technique that was judged to be similarly resource-demanding, where required. A
paper was classified as type 2 if it used any type 2 technique, even if it mainly used
type 1 techniques. In addition, each paper was attributed to one of the nine broad
topical neuroscience themes, as put forward based on attendance at the Society for
Neuroscience annual meeting (see also Ref. 18). Specifically, topics included (i)
techniques, (ii) cognition, (iii) motivation and emotion, (iv) physiology and
behaviour, (v) motor systems, (vi) sensory systems, (vii) neurodegeneration and
injury, (viii) excitability, synapses and glia and (ix) development. Finally, for all n
= 265 African and n= 232 non-African papers that were published in journals
with an IF ≥ 5, we also extracted information on funding. We used only this subset
of publications because this task was unusually time-consuming in view of
incomplete standardisation across publishing outlets and the large diversity of
funders worldwide. Data on international flights was taken from OpenFlights.org,
an open-source database of all major flight routes worldwide. The corresponding
dataset is publicly available at https://github.com/jpatokal/openflights/. Data and
sources for other metrics, including GDP, R&D spending in purchasing power
parity (PPP), GERD, population, etc. are detailed in the raw data tables provided
on GitHub (see ‘Data availability’). PPP is a measurement of prices in different
countries that uses the prices of specific goods to compare the absolute purchasing
power of the countries’ currencies46. Starting from raw Microsoft Excel tables
provided, all data analysis was performed in Igor Pro 6 (Wavemetrics) and GNU-R.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data were retrieved from PubMed at https://pubmed.ncbi.nlm.nih.gov/. All data is freely
available without restriction at https://github.com/BadenLab/AfricanNeuroscience and
https://zenodo.org/badge/latestdoi/267297804 (see Ref. 47). Source data are provided with
this paper.
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